Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Importance Perioperative cardiovascular complications occur in 3% of hospitalizations for
noncardiac surgery in the US. This review summarizes evidence regarding cardiovascular …

Perioperative cardiovascular complications are important causes of morbidity and mortality
associated with non-cardiac surgery, particularly in patients with coronary artery disease …

Background: Uncertainty remains about the effects of aspirin in patients with prior
percutaneous coronary intervention (PCI) having noncardiac surgery. Objective: To evaluate …

Background: Guidelines recommend postponing surgery for at least 6 months after treatment
with a drug-eluting stent by percutaneous coronary intervention (DES-PCI). Objectives: The …

Perioperative management of antithrombotic therapy in patients treated with coronary stents
undergoing surgery remains poorly defined. Importantly, surgery represents a common …

Abstract Aim The “2024 aha/acc/acs/asnc/hrs/sca/scct/scmr/svm Guideline for Perioperative
Cardiovascular Management for Noncardiac Surgery” provides recommendations to guide …

The Clinical Practice Guidelines for perioperative cardiovascular evaluation and
management for non-cardiac surgery were initially developed by the Japanese Circulation …

Perioperative management of antiplatelet therapy (APT) should be individually tailored
based on consensus among the anesthesiologist, cardiologist, surgeon, and patient to …

Background Prior registry data suggest that 4%-20% of patients require noncardiac surgery
(NCS) within 2 years of percutaneous coronary intervention (PCI). Contemporary data on …